Industry News
Pharmaceutical Industry News
A DOE-Based Approach to Optimizing T-Cell Expansion
A DOE-Based Approach to Optimizing T-Cell Expansion ncavazza Tue, 03/01/2022 - 14:16
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line kdunleavy Tue, 03/01/2022 - 12:52
FibroGen’s roxadustat safety mess draws SEC scrutiny as AstraZeneca-partnered anemia drug remains in limbo
FibroGen’s roxadustat safety mess draws SEC scrutiny as AstraZeneca-partnered anemia drug remains in limbo aliu Tue, 03/01/2022 - 11:25
Gilead’s HIV prospect lenacapavir hits FDA approval snag amid vial compatibility concerns
Gilead's HIV prospect lenacapavir hits FDA approval snag amid vial compatibility concerns fkansteiner Tue, 03/01/2022 - 10:48
With sales sagging, Amarin sees progress on new Vascepa digital effort in the US
With sales sagging, Amarin sees progress on new Vascepa digital effort in the US kdunleavy Tue, 03/01/2022 - 10:03
With Bayer’s new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long? aliu Tue, 03/01/2022 - 10:01
CTI BioPharma clinches long-awaited FDA approval for myelofibrosis blockbuster prospect Vonjo
CTI BioPharma clinches long-awaited FDA approval for myelofibrosis blockbuster prospect Vonjo fkansteiner Tue, 03/01/2022 - 09:57
FDA pushes back GC Pharma’s blood derivative approval due to inspection delay
FDA pushes back GC Pharma's blood derivative approval due to inspection delay jkeenan Tue, 03/01/2022 - 09:56
Lung safety review delays FDA decision on United’s Tyvaso DPI
Lung safety review delays FDA decision on United's Tyvaso DPI ntaylor Tue, 03/01/2022 - 09:40
Hovione allies with Zerion to boost oral drug bioavailability
Hovione allies with Zerion to boost oral drug bioavailability ntaylor Tue, 03/01/2022 - 09:36
CureVac launches ‘RNA Printer’ subsidiary to provide clients with flexible mRNA manufacturing
CureVac launches 'RNA Printer' subsidiary to provide clients with flexible mRNA manufacturing jkeenan Tue, 03/01/2022 - 08:44
Mindy Kaling becomes the face of national ‘PurpleStride’ pancreatic cancer fundraiser with backing from Ipsen, AbbVie
Mindy Kaling becomes the face of national 'PurpleStride' pancreatic cancer fundraiser with backing from Ipsen, AbbVie nmissakian Tue, 03/01/2022 - 08:36
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono fkansteiner Tue, 03/01/2022 - 08:06
Johnson & Johnson goes early on myasthenia gravis awareness push, eyeing argenx, AstraZeneca battle ahead
Johnson & Johnson goes early on myasthenia gravis awareness push, eyeing argenx, AstraZeneca battle ahead badams Tue, 03/01/2022 - 07:07
Johnson & Johnson, Legend’s CAR-T Carvykti enters myeloma ring with FDA nod
Johnson & Johnson, Legend's CAR-T Carvykti enters myeloma ring with FDA nod aliu Mon, 02/28/2022 - 12:59
COPD Foundation links arms with Ena on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu
COPD Foundation links arms with Ena on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu ntaylor Mon, 02/28/2022 - 11:31
Trevi revs up extended-release opioid cough program, exiting phase 2 early and racing into next stage
Trevi revs up extended-release opioid cough program, exiting phase 2 early and racing into next stage ntaylor Mon, 02/28/2022 - 11:28
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win fkansteiner Mon, 02/28/2022 - 10:52
Lexicon pulls FDA submission for sotagliflozin to fix ‘technical issue,’ plans prompt refiling
Lexicon pulls FDA submission for sotagliflozin to fix 'technical issue,' plans prompt refiling esagonowsky Mon, 02/28/2022 - 10:34
Bristol Myers’ Opdivo steps in FDA fast lane for potential first-in-class nod in pre-surgery lung cancer
Bristol Myers' Opdivo steps in FDA fast lane for potential first-in-class nod in pre-surgery lung cancer aliu Mon, 02/28/2022 - 09:10